Several executive orders recently signed by US President Donald Trump may have significant implications for the US Food and Drug Administration ...

Tazbaz was director of the FDA’s Digital Health Center of Excellence for two years, leading on policies involving artificial ...

Tazbaz was director of the FDA’s Digital Health Center of Excellence for two years, leading key policies on artificial intelligence and software as a medical device.

The Budget Estimates (BE) for the Centrally Sponsored Scheme of Strengthening of States Drug Regulatory System (SSDRS) for the fiscal year 2025-26 is Rs. 50 crore, around 33 per cent less than the ...

Nuance Audio, new "hearing glasses" from EssilorLuxottica, have received FDA clearance and "a CE marking under the Medical ...

What will the industry face or achieve in 2025? These trends will be critical in medical device cybersecurity.

In the EU, the AI Act has been approved, carrying significant implications for medical device, technology, and pharmaceutical firms. In the US, ...

CEO John McCutcheon is adamant the US Food & Drug Administration (FDA) will approve the company's Wise, the world’s first ...

The Africa Centres for Disease Control and Prevention (Africa CDC) and African Union Development Agency - New Partnership for Africa's Development (AUDA-NEPAD) are proud to announce the signing of a ...

The healthcare industry is evolving rapidly, and telemedicine has become a cornerstone of modern healthcare delivery. With the global telemedicine market projected to reach 462.19...Read More The post ...

Susan Krause of Rosemount alleges New Jersey-based Integra LifeSciences pressured her to lie to regulators. Integra says ...

After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and ...